These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 20873786

  • 21. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
    Kaur A, Jain S, Tiwary AK.
    Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
    [Abstract] [Full Text] [Related]

  • 22. Albumin-based nanoparticles as potential controlled release drug delivery systems.
    Elzoghby AO, Samy WM, Elgindy NA.
    J Control Release; 2012 Jan 30; 157(2):168-82. PubMed ID: 21839127
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B, Garcia-Bennett AE.
    Adv Drug Deliv Rev; 2010 Mar 08; 62(3):362-74. PubMed ID: 19900497
    [Abstract] [Full Text] [Related]

  • 26. Redox-responsive nanocapsules for intracellular protein delivery.
    Zhao M, Biswas A, Hu B, Joo KI, Wang P, Gu Z, Tang Y.
    Biomaterials; 2011 Aug 08; 32(22):5223-30. PubMed ID: 21514660
    [Abstract] [Full Text] [Related]

  • 27. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles.
    Nehilla BJ, Allen PG, Desai TA.
    ACS Nano; 2008 Mar 08; 2(3):538-44. PubMed ID: 19206580
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W, Ko H, Park J, Lim E, Park SB, Park YJ, Yoon HG, Suh JS, Haam S, Huh YM.
    Biotechnol Bioeng; 2008 Feb 01; 99(2):442-54. PubMed ID: 17625788
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK.
    J Control Release; 2009 May 21; 136(1):2-13. PubMed ID: 19331856
    [Abstract] [Full Text] [Related]

  • 35. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J, Chen XG, Li YY, Liu CS.
    Nanomedicine; 2007 Dec 21; 3(4):258-65. PubMed ID: 17962086
    [Abstract] [Full Text] [Related]

  • 36. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
    Gelperina S, Maksimenko O, Khalansky A, Vanchugova L, Shipulo E, Abbasova K, Berdiev R, Wohlfart S, Chepurnova N, Kreuter J.
    Eur J Pharm Biopharm; 2010 Feb 21; 74(2):157-63. PubMed ID: 19755158
    [Abstract] [Full Text] [Related]

  • 37. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug.
    Stover TC, Kim YS, Lowe TL, Kester M.
    Biomaterials; 2008 Jan 21; 29(3):359-69. PubMed ID: 17964645
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Challenges in design of translational nanocarriers.
    Sun Q, Radosz M, Shen Y.
    J Control Release; 2012 Dec 10; 164(2):156-69. PubMed ID: 22664472
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.